Spots Global Cancer Trial Database for aldoxorubicin
Every month we try and update this database with for aldoxorubicin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors | NCT01673438 | Advanced Solid ... | aldoxorubicin | 18 Years - | ImmunityBio, Inc. | |
| QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer | NCT03574649 | Non Small Cell ... | Nab-paclitaxel Cisplatin 5Fluorouracil Cyclophosphamid... ETBX-011 ETBX-051 ETBX-061 GI-4000 GI-6301 Aldoxorubicin Avelumab ALT-803 haNK Docetaxel carboplatin | 18 Years - | ImmunityBio, Inc. | |
| Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer | NCT02200757 | Metastatic Smal... | Aldoxorubicin Topotecan | 18 Years - | CytRx | |
| Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors | NCT01706835 | Advanced Solid ... | aldoxorubicin | 18 Years - | ImmunityBio, Inc. | |
| Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer | NCT02200757 | Metastatic Smal... | Aldoxorubicin Topotecan | 18 Years - | CytRx | |
| Phase 3 Study to Treat Patients With Soft Tissue Sarcomas | NCT02049905 | Metastatic, Loc... | Aldoxorubicin Investigator's ... | 15 Years - | ImmunityBio, Inc. | |
| Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors | NCT02235688 | Metastatic Soli... | aldoxorubicin aldoxorubicin aldoxorubicin gemcitabine | 15 Years - 80 Years | ImmunityBio, Inc. | |
| Phase 1b Study to Investigate the Safety and Maximum Tolerated Dose of Aldoxorubicin (INNO-206) Plus Doxorubicin HCL in Subjects With Advanced Solid Tumors | NCT01673438 | Advanced Solid ... | aldoxorubicin | 18 Years - | ImmunityBio, Inc. | |
| Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors | NCT01706835 | Advanced Solid ... | aldoxorubicin | 18 Years - | ImmunityBio, Inc. | |
| A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma | NCT02029430 | Kaposi's Sarcom... HIV Positive AIDS | aldoxorubicin | 18 Years - | ImmunityBio, Inc. | |
| QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer | NCT03574649 | Non Small Cell ... | Nab-paclitaxel Cisplatin 5Fluorouracil Cyclophosphamid... ETBX-011 ETBX-051 ETBX-061 GI-4000 GI-6301 Aldoxorubicin Avelumab ALT-803 haNK Docetaxel carboplatin | 18 Years - | ImmunityBio, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
